Weiss Amir Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$883,406.11

Insider Activity of Weiss Amir

According to the SEC Form 4 filings, Weiss Amir, being in a position of

  1. Chief Accounting Officer at Teva Pharmaceutical Industries Limited,
    оver the last 12 months, has bought 0 shares, and sold 44724 shares for $1.41M,
    over all time since 2023-08-04, has bought 0 shares, and sold 106606 shares for $2.3M.

Biography of Weiss Amir

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,411,8134100

Comparison of Insiders on Amount of Buys and Sells

2026-08-21SaleTeva Pharmaceutical Industries Limited
TEVA
Chief Accounting Officer
9,445
0.0008%
$37.62$355,301+5.28%
2026-05-06SaleTeva Pharmaceutical Industries Limited
TEVA
Chief Accounting Officer
10,679
0.0009%
$36.00$384,444-0.91%
2025-12-16SaleTeva Pharmaceutical Industries Limited
TEVA
Chief Accounting Officer
12,300
0.0011%
$30.20$371,504+13.22%
2025-11-06SaleTeva Pharmaceutical Industries Limited
TEVA
Chief Accounting Officer
12,300
0.0013%
$24.44$300,564+37.45%
2024-05-16SaleTeva Pharmaceutical Industries Limited
TEVA
Chief Accounting Officer
12,635
0.0011%
$16.65$210,377+4.79%
2024-05-15SaleTeva Pharmaceutical Industries Limited
TEVA
Chief Accounting Officer
15,500
0.0014%
$16.80$260,417+1.79%
2024-02-01SaleTeva Pharmaceutical Industries Limited
TEVA
Chief Accounting Officer
31,766
0.003%
$12.37$392,955+36.28%
2023-08-04SaleTeva Pharmaceutical Industries Limited
TEVA
Chief Accounting Officer
1,981.41
0.0002%
$9.92$19,658+24.18%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.